U
GBIM

UBS’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

UBS’s Portfolio GBIM Stock Details GBIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Buy
+551
New +$5.63K ﹤0.01% 9710

Other funds holding GBIM

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $2.93B AUM 4.27% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS's GBIM Position: Q3 2014 in Review

UBS opened a new position in GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q3 2014: 551 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #9710 among its holdings.

17 funds tracked by Wall St. Rank hold GBIM as of Q3 2014.

  • UBS held 551 shares of GLOBEIMMUNE INC COM STK (DE) worth $4K as of Q3 2014.
  • GLOBEIMMUNE INC COM STK (DE) was a new UBS position in Q3 2014.
  • GLOBEIMMUNE INC COM STK (DE) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9710 holding.
  • 17 funds tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.